Literature DB >> 26236651

The Effect of Hypoxia on Mesenchymal Stem Cell Biology.

Mostafa Ejtehadifar1, Karim Shamsasenjan2, Aliakbar Movassaghpour1, Parvin Akbarzadehlaleh3, Nima Dehdilani1, Parvaneh Abbasi1, Zahra Molaeipour1, Mahshid Saleh1.   

Abstract

Although physiological and pathological role of hypoxia have been appreciated in mammalians for decades however the cellular biology of hypoxia more clarified in the past 20 years. Discovery of the transcription factor hypoxia-inducible factor (HIF)-1, in the 1990s opened a new window to investigate the mechanisms behind hypoxia. In different cellular contexts HIF-1 activation show variable results by impacting various aspects of cell biology such as cell cycle, apoptosis, differentiation and etc. Mesenchymal stem cells (MSC) are unique cells which take important role in tissue regeneration. They are characterized by self-renewal capacity, multilineage potential, and immunosuppressive property. Like so many kind of cells, hypoxia induces different responses in MSCs by HIF- 1 activation. The activation of this molecule changes the growth, multiplication, differentiation and gene expression profile of MSCs in their niche by a complex of signals. This article briefly discusses the most important effects of hypoxia in growth kinetics, signalling pathways, cytokine secretion profile and expression of chemokine receptors in different conditions.

Entities:  

Keywords:  Hypoxia; Hypoxia-inducible factor; Mesenchymal stem cells; Niche

Year:  2015        PMID: 26236651      PMCID: PMC4517092          DOI: 10.15171/apb.2015.021

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  104 in total

1.  Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers.

Authors:  H S Goodwin; A R Bicknese; S N Chien; B D Bogucki; C O Quinn; D A Wall
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

2.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

3.  Induction of multilineage markers in human myeloma cells and their down-regulation by interleukin 6.

Authors:  Shangqin Liu; Ken-ichiro Otsuyama; Zi Ma; Saeid Abroun; Karim Shamsasenjan; Jakia Amin; Hideki Asaoku; Michio M Kawano
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

4.  Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy.

Authors:  Christelle P El-Haibi; George W Bell; Jiangwen Zhang; Anthony Y Collmann; David Wood; Cally M Scherber; Eva Csizmadia; Odette Mariani; Cuihua Zhu; Antoine Campagne; Mehmet Toner; Sangeeta N Bhatia; Daniel Irimia; Anne Vincent-Salomon; Antoine E Karnoub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-02       Impact factor: 11.205

Review 5.  The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches.

Authors:  Ruud Das; Holger Jahr; Gerjo J V M van Osch; Eric Farrell
Journal:  Tissue Eng Part B Rev       Date:  2010-04       Impact factor: 6.389

6.  Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.

Authors:  H M Lazarus; S E Haynesworth; S L Gerson; A I Caplan
Journal:  J Hematother       Date:  1997-10

7.  Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment.

Authors:  Morad Bensidhoum; Alain Chapel; Sabine Francois; Christelle Demarquay; Christelle Mazurier; Loic Fouillard; Sandrine Bouchet; Jean Marc Bertho; Patrick Gourmelon; Jocelyne Aigueperse; Pierre Charbord; Norbert Claude Gorin; Dominique Thierry; Manuel Lopez
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

8.  Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification.

Authors:  Soraya Carrancio; Natalia López-Holgado; Fermín M Sánchez-Guijo; Eva Villarón; Victoria Barbado; Soraya Tabera; María Díez-Campelo; Juan Blanco; Jesús F San Miguel; M Consuelo Del Cañizo
Journal:  Exp Hematol       Date:  2008-05-12       Impact factor: 3.084

9.  Mesenchymal precursor cells in the blood of normal individuals.

Authors:  N J Zvaifler; L Marinova-Mutafchieva; G Adams; C J Edwards; J Moss; J A Burger; R N Maini
Journal:  Arthritis Res       Date:  2000-08-31

10.  Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1.

Authors:  Woochul Chang; Chang Youn Lee; Jun-Hee Park; Moon-Seo Park; Lee-So Maeng; Chee Soon Yoon; Min Young Lee; Ki-Chul Hwang; Yong-An Chung
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

View more
  61 in total

1.  EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210.

Authors:  Yiyan Qiu; Yang Chen; Tenghui Zeng; Weizhuang Guo; Wenyu Zhou; Xinjian Yang
Journal:  Mol Biol Rep       Date:  2016-01-16       Impact factor: 2.316

Review 2.  Effect of hypoxia on human adipose-derived mesenchymal stem cells and its potential clinical applications.

Authors:  Jane Ru Choi; Kar Wey Yong; Wan Kamarul Zaman Wan Safwani
Journal:  Cell Mol Life Sci       Date:  2017-02-21       Impact factor: 9.261

Review 3.  Mesenchymal Stem Cell/Multipotent Stromal Cell Augmentation of Wound Healing: Lessons from the Physiology of Matrix and Hypoxia Support.

Authors:  Kyle Sylakowski; Andrew Bradshaw; Alan Wells
Journal:  Am J Pathol       Date:  2020-04-12       Impact factor: 4.307

4.  Altered expression of circular RNAs in human placental chorionic plate-derived mesenchymal stem cells pretreated with hypoxia.

Authors:  Xunsha Sun; Yulin Jin; Qihua Liang; Jie Tang; Jinsong Chen; Qiuxia Yu; Fatao Li; Yan Li; Jieying Wu; Shaoqing Wu
Journal:  J Clin Lab Anal       Date:  2018-11-28       Impact factor: 2.352

Review 5.  In Vitro Innovation of Tendon Tissue Engineering Strategies.

Authors:  Maria Rita Citeroni; Maria Camilla Ciardulli; Valentina Russo; Giovanna Della Porta; Annunziata Mauro; Mohammad El Khatib; Miriam Di Mattia; Devis Galesso; Carlo Barbera; Nicholas R Forsyth; Nicola Maffulli; Barbara Barboni
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

6.  Low-oxygen and knock-out serum maintain stemness in human retinal progenitor cells.

Authors:  Deepti Singh; Pierre C Dromel; Michael Young
Journal:  Mol Biol Rep       Date:  2020-01-16       Impact factor: 2.316

Review 7.  Methods of Liver Stem Cell Therapy in Rodents as Models of Human Liver Regeneration in Hepatic Failure.

Authors:  Nasser Hashemi Goradel; Masoud Darabi; Karim Shamsasenjan; Mostafa Ejtehadifar; Sarah Zahedi
Journal:  Adv Pharm Bull       Date:  2015-09-19

8.  Cross talk between 26S proteasome and mitochondria in human mesenchymal stem cells' ability to survive under hypoxia stress.

Authors:  Ramada R Khasawneh; Ejlal Abu-El-Rub; Abdullah Omar Serhan; Bashar Omar Serhan; Hadeel Abu-El-Rub
Journal:  J Physiol Sci       Date:  2019-11-02       Impact factor: 2.781

Review 9.  Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.

Authors:  Joo Youn Oh; Ryang Hwa Lee
Journal:  Prog Retin Eye Res       Date:  2021-03-26       Impact factor: 21.198

10.  Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases.

Authors:  Angela Ceruso; Ainhoa Gonzalez-Pujana; Manoli Igartua; Edorta Santos-Vizcaino; Rosa Maria Hernandez
Journal:  Drug Deliv Transl Res       Date:  2021-02-25       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.